Coming Soon! NIDDK-CR is revising its policy to align with the final NIH Data Management and Sharing (DMS) policy and NIDDK DMS guidance.
Skip to Main Content
Home
chevron_right Studies chevron_right Ancillary Studies
chevron_right Serum Signature Analysis of participants of the TrialNet Canakinumab (TNC) Trial
Serum Signature Analysis of participants of the TrialNet Canakinumab (TNC) Trial
Main study |
TrialNet 14: Effects of Canakinumab on the Progression of Type 1 Diabetes in New Onset Subjects |
Contact name |
Martin Hessner, PhD |
Contact phone |
414-456-4496 |
Contact email |
mhessner@mcw.edu |
PI name |
Martin Hessner, PhD |
Owner |
Sarah Muller |
Lab name |
Mary Kaldunski |
Lab email |
mlkal@mcw.edu |
Lab phone |
414-456-4904 |
Institution |
The Medical College of Wisconsin |
Address |
HRC 5th Floor H58508701 Watertown Plank Road |
City |
Milwaukee |
State |
WI |
Zip code |
53226 |